Quality of Life in Asthmatic Children at School Age
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Asthma is the most common chronic disease in childhood [1]. The advantage of an educational program in a global strategy of care has been established in asthma (decrease of nocturnal asthma, absence from work and school) [2, 3]. Therapeutic education of the patient permits the reduction of the rate of hospitalization, of the rate of emergencies visits and non-programmed visits. [3].
The WHO defines quality of life as an individual's perception of its place in existence, in the context of culture and value system in which he lives, in relation to its objectives, expectations, standards and concerns [4]. The basic point of this concept is the notion of perception, emphasizing the perspective of the person. It is a broad concept affected in a complex way by the subject's physical health, psychological state, level of independence, social relationships, and its relations with its environment. In the field of health, analyzing the quality of life includes objective aspects (living conditions, functional health) and subjective aspects (satisfaction, happiness, well-being) that allow to understand the situation of people in whole.
As defined by the WHO-Europe report published in 1996 [5], the therapeutic education aims to help patients acquire or maintain the competencies they need to best manage their lives with a chronic disease.
It is entirely part of the management of the patient. It includes organized activities designed to make patients aware and informed of their disease, of care organization and hospital procedures, and the behaviors related to health and disease. This is to help them and their families understand their illness and treatment, to work together and to gain autonomy from their disease in order to help maintain and improve their quality of life [6].
However, studies demonstrating the effectiveness of therapeutic patient education are still very few, especially in children. The need for prospective studies including the evaluation of the impact on quality of life was highlighted in a recent Cochrane meta-analysis [7]. It seems interesting for the authors to assess the improvement of the quality of life after educational sessions in children at school-age.
| Condition | Intervention |
|---|---|
|
Asthma |
Behavioral: Educational program: consultation with paediatric pulmonologist |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | Quality of Life in Asthmatic Children at School Age : Influence of Therapeutic Education |
- AUQUEI questionnaire (Asthma Caregiver's Quality of Life) [ Time Frame: 3 or 4 months after the diagnosis of asthma ] [ Designated as safety issue: Yes ]
- Clinical control of asthma measured by the Asthma Control Test [ Time Frame: 3 or 4 months after the diagnosis of asthma ] [ Designated as safety issue: Yes ]
- Frequence and severity of the exacerbations [ Time Frame: 3 or 4 months after the diagnosis of asthma ] [ Designated as safety issue: Yes ]
- assessment of pulmonary function by spirometry [ Time Frame: 3 or 4 months after the diagnosis of asthma ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 40 |
| Study Start Date: | December 2011 |
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
-
Behavioral: Educational program: consultation with paediatric pulmonologist
Longitudinal prospective study
Eligibility| Ages Eligible for Study: | 5 Years to 10 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- School-aged (from 5 to 10 years old) asthmatic children consulting for the first time a paediatric pulmonologist
Exclusion Criteria:
- Other non-atopic chronic disease
Contacts and Locations| Contact: Patrick LACARIN | 04 73 75 11 95 | placarin@chu-clermontferrand.fr |
| Principal Investigator: | André LABBE, Md, PhD | University Hospital, Clermont-Ferrand |
More Information
No publications provided
| Responsible Party: | University Hospital, Clermont-Ferrand |
| ClinicalTrials.gov Identifier: | NCT01475916 History of Changes |
| Other Study ID Numbers: | CHU-0105 |
| Study First Received: | September 23, 2011 |
| Last Updated: | November 17, 2011 |
| Health Authority: | France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé |
Keywords provided by University Hospital, Clermont-Ferrand:
|
Asthma Educational program Quality of life School-aged children |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013